Licensing Agreement For "Olutasidenib" With Orient Europharma In Taiwan
May 1 (Reuters) - Orient Europharma Co Ltd 4120.TWO: KISSEI PHARMACEUTICAL CO LTD: LICENSING AGREEMENT FOR "OLUTASIDENIB" WITH ORIENT EUROPHARMA IN TAIWAN KISSEI PHARMACEUTICAL CO LTD: KISSEI WILL RECEIVE AN UPFRONT PAYMENT AND MILESTONE PAYMENTS BASED ON PROGRESS OF COMMERCIALIZATION IN TAIWAN, AND WILL SUPPLY FORMULATION TO OEP Source text: ID:nTSqa7e05a Further company coverage: 4120.TWO (Reporting by Tokyo Newsroom) ((+81345201189;))